COX-2 inhibitors as adjunctive therapy in schizophrenia: Rationale for use and evidence to date

Michael Riedel, Martin Strassnig, Markus J. Schwarz, Norbert Müller

Research output: Contribution to journalReview articlepeer-review

35 Scopus citations

Fingerprint

Dive into the research topics of 'COX-2 inhibitors as adjunctive therapy in schizophrenia: Rationale for use and evidence to date'. Together they form a unique fingerprint.

Medicine & Life Sciences